BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 200,000 Value ($000) $225 Avg Close — Range —
Q3 2025
Shares 200,000 Value ($000) $198 Avg Close — Range —
Q2 2025
Shares 200,000 Value ($000) $187 Avg Close — Range —
Q1 2025
Shares 200,000 Value ($000) $180 Avg Close — Range —
Q3 2023
Shares 200,000 Value ($000) $152 Avg Close — Range —
Q2 2023
Shares 200,000 Value ($000) $123 Avg Close — Range —